NRX Pharmaceuticals's total assets for Q2 2025 were $4.84M, a decrease of -36.26% from the previous quarter. NRXP total liabilities were $40.45M for the fiscal quarter, a 23.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.